Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rhythm Pharmaceuticals Inc
(NQ:
RYTM
)
39.72
-0.20 (-0.50%)
Streaming Delayed Price
Updated: 12:51 PM EDT, Jun 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rhythm Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...
Via
Benzinga
Expert Ratings for Rhythm Pharmaceuticals
September 08, 2022
Rhythm Pharmaceuticals (NASDAQ:RYTM) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition
August 02, 2022
Via
Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
September 08, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.
Via
Benzinga
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
September 08, 2022
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Rhythm Secures European Commission Marketing Authorization For Genetic Disease Candidate
September 06, 2022
The European Commission (EC) has expanded the marketing authorization for Rhythm’s (NASDAQ: RYTM) lead drug product IMCIVREE (setmelanotide) to include the treatment of obesity and control of hunger...
Via
Benzinga
Jim Cramer Says He's Passing On This $10 Social Media Stock As It's 'Losing Money'
August 25, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a "very interesting company.
Via
Benzinga
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
August 16, 2022
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via
Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
August 15, 2022
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New...
Via
Benzinga
Why Goldman Sachs Raised Its Price Target On This Biotech Stock By Nearly 5X
August 08, 2022
The initial phase II data in patients with hypothalamic obesity (HO) has transformed the opportunity for Rhythm Pharmaceuticals Inc’s (NASDAQ: RYTM) Imcivree, according to Goldman Sachs.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
Moderna, PayPal And Some Other Big Gainers From Wednesday
August 04, 2022
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Upgrades
Via
Benzinga
What 7 Analyst Ratings Have To Say About Rhythm Pharmaceuticals
August 03, 2022
Over the past 3 months, 7 analysts have published their opinion on Rhythm Pharmaceuticals (NASDAQ:RYTM) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 02, 2022
Via
Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
August 04, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June
August 02, 2022
U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday.
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Rhythm Pharmaceuticals: Q2 Earnings Insights
August 02, 2022
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Rhythm Pharmaceuticals's Earnings: A Preview
August 01, 2022
Rhythm Pharmaceuticals (NASDAQ:RYTM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Recap Of Friday's Biotech Catalysts - End Of The Day Summary
July 22, 2022
Via
Benzinga
Rhythm Has Tripled In A Week And Quintupled Since May — Here's Why
July 21, 2022
The company looks to take on behemoths Novo Nordisk and Eli Lilly in obesity drugs.
Via
Investor's Business Daily
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 20, 2022
Via
Benzinga
Stocks Shift Higher as Strong Earnings Continue
July 20, 2022
The broader market has rebounded from this morning's losses midday.
Via
Talk Markets
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
Tech Shares Move Higher, Nasdaq Jumps 200 Points
July 20, 2022
U.S. stocks traded higher midway through trading, with the NASDAQ Composite gaining more than 200 points on Wednesday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.